Clover Biopharmaceuticals, Ltd.
CBPHFDrugs in Pipeline
3
Phase 3 Programs
2
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
Candidate vaccine, SCB-2019
COVID-19
CpG 1018/Alum-adjuvanted SCB-2019 vaccine
COVID-19
SCB-1019T
RSV Infection
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Candidate vaccine, SCB-2019 | Phase 3 | COVID-19 | - | - |
CpG 1018/Alum-adjuvanted SCB-2019 vaccine | Phase 3 | COVID-19 | - | - |
SCB-1019T | Phase 2 | RSV Infection | - | - |
Frequently asked questions
What is in Clover Biopharmaceuticals, Ltd.'s drug pipeline?→
CatalystAlert tracks 3 drug candidates in Clover Biopharmaceuticals, Ltd.'s (CBPHF) pipeline across Phase 3, Phase 2. Its lead program is Candidate vaccine, SCB-2019 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Clover Biopharmaceuticals, Ltd.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Clover Biopharmaceuticals, Ltd. (CBPHF) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track CBPHF biotech catalysts?→
Add CBPHF to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Clover Biopharmaceuticals, Ltd.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.